Peginterferon alfa-2b [PegIntron®]

DRUG2 trials

Sponsors

Hoffmann-La Roche

Conditions

Hepatitis C, Chronic

Unknown Phase

PROPHESYS 3: Observational Study on Predictors of Response in Patients With Treatment-naïve Chronic Hepatitis C Initiated on Treatment With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b

CompletedNCT01066819

Hoffmann-La RocheHepatitis C, Chronic

Start: 2008-01-31End: 2011-08-31Updated: 2016-08-08

PROPHESYS 2: An Observational Study on Predictors of Response in Treatment-naïve Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b

CompletedNCT01066793

Hoffmann-La RocheHepatitis C, Chronic

Start: 2007-10-31End: 2011-05-31Updated: 2016-05-09